Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation

Clinical Biochemistry

Volumn 46, Issue 4-5, 2013, Pages 385-387

  Wang, Cui Zhu ^a   Lin, Jiang ^a   Qian, Jun ^a   Shao, Rui ^a   Xue, Di ^a   Qian, Wei ^a   Xiao, Gao Fei ^a   Deng, Zhao qun ^a   Yang, Jing ^a   Li, Yun ^a   Chen, Xing xing ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Diffuse large B cell lymphoma; High resolution melting analysis; Mutation; MYD88

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88;

ARTICLE; DIAGNOSTIC ACCURACY; DNA SEQUENCE; GENETIC SCREENING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; MYELOID DIFFERENTIATION FACTOR 88; SENSITIVITY AND SPECIFICITY; TRANSITION TEMPERATURE;

EID: 84873706943     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.11.007     Document Type: Article

References (10)

1. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
2. Lenz G., Staudt L.M. Aggressive lymphomas. N Engl J Med 2010, 362:1417-1429.
3. Ngo V.N., Young R.M., Schmitz R., Jhavar S., Xiao W., Lim K.H., et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011, 470:115-119.
4. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-282.
5. Qian J., Lin J., Yao D.M., Chen Q., Xiao G.F., Ji R.B., et al. Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform. Clin Chim Acta 2010, 411:2097-2100.
6. Lord K.A., Hoffman-Liebermann B., Liebermann D.A. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 1990, 5:1095-1097.
7. Liebermann D.A., Hoffman B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 2002, 16:527-541.
8. Puente X.S., Pinyol M., Quesada V., Conde L., Ordóñez G.R., Villamor N., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011, 475:101-105.
9. Montesinos-Rongen M., Godlewska E., Brunn A., Wiestler O.D., Siebert R., Deckert M. Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma. Acta Neuropathol 2011, 122:791-792.
10. Treon S.P., Xu L., Yang G., Zhou Y., Liu X., Cao Y., et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med 2012, 367:826-833.